Eczema exacerbated and Hypercalcaemia aggravated

Summary:

Hypercalcaemia aggravated is found among people with Eczema exacerbated, especially for people who are male, 60+ old.

The study analyzes which people have Hypercalcaemia aggravated with Eczema exacerbated. It is created by eHealthMe based on reports of 17 people who have Eczema exacerbated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Eczema exacerbated?

Eczema exacerbated is found to be associated with 1,253 drugs and 531 conditions by eHealthMe. Check the latest studies of Eczema exacerbated.

What is Hypercalcaemia aggravated?

Hypercalcaemia aggravated (elevated calcium (ca+) level in the blood. (norma) is found to be associated with 933 drugs and 343 conditions by eHealthMe. Check the latest studies of Hypercalcaemia aggravated.



On Jul, 11, 2026

17 people who have Eczema Exacerbated and Hypercalcaemia Aggravated are studied.

Would you have Hypercalcaemia aggravated when you have Eczema exacerbated?

Gender of people who have Eczema Exacerbated and experienced Hypercalcaemia Aggravated *:

  • female: 23.53 %
  • male: 76.47 %

Age of people who have Eczema Exacerbated and experienced Hypercalcaemia Aggravated *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 5.88 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 94.12 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 14 people, 82.35%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 64.71%
  3. Pain: 3 people, 17.65%
  4. Laxative Supportive Care: 3 people, 17.65%
  5. Indigestion: 3 people, 17.65%
  6. Hypersensitivity: 3 people, 17.65%
  7. Anorectal Discomfort: 3 people, 17.65%
  8. Skin Blushing/flushing (a sudden reddening of the face, neck): 1 person, 5.88%
  9. Reflux Gastritis (a condition in which the lining of a person's stomach becomes inflamed as a result of exposure to bile): 1 person, 5.88%
  10. Birth Control: 1 person, 5.88%

Common drugs taken by these people *:

  1. Sorafenib: 3 people, 17.65%
  2. Lansoprazole: 3 people, 17.65%
  3. Indapamide: 3 people, 17.65%
  4. Megace: 2 people, 11.76%
  5. Diclofenac: 2 people, 11.76%
  6. Megestrol Acetate: 1 person, 5.88%
  7. Elidel: 1 person, 5.88%
  8. Diclofenac Sodium: 1 person, 5.88%
  9. Depo-Provera: 1 person, 5.88%

Common symptoms for these people *:

  1. Granulomatous Pneumonitis (a mass of inflamed granulation tissue of lung): 9 people, 52.94%
  2. Traumatic Lung Injury: 4 people, 23.53%
  3. Pneumonia: 4 people, 23.53%
  4. Spinal Cord Compression: 3 people, 17.65%
  5. Pancreatitis (inflammation of pancreas): 3 people, 17.65%
  6. Gallstones (stone formation by bile component): 3 people, 17.65%
  7. Dehydration (dryness resulting from the removal of water): 3 people, 17.65%
  8. Confusional State: 3 people, 17.65%
  9. Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 2 people, 11.76%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hypercalcaemia aggravated?

- Check whether Hypercalcaemia aggravated is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hypercalcaemia aggravated:

All the conditions that are associated with Hypercalcaemia aggravated:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hypercalcaemia aggravated and Eczema exacerbated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: